Published Online
on July 30, 2009

A more recent version of this article appeared on September 1, 2009

This Article Full Text (PDF) All Versions of this Article: 40/9/3159    most recent STROKEAHA.109.559054v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Hackam, D. G. PubMed PubMed Citation Articles by Hackam, D. G. Related Collections ACE/Angiotension receptors Cerebrovascular disease/stroke Primary and Secondary Stroke Prevention Other Stroke Treatment - Medical

Submitted on May 28, 2009
Accepted on May 29, 2009

Angiotensin Receptor Blockers Should Be Regarded as First-Line Drugs for Stroke Prevention in Both Primary and Secondary Prevention Settings. Yes

Daniel G. Hackam MD, PhD, FRCPC^*

From the Department of Medicine, Division of Clinical Neurological Sciences, University of Western Ontario, and London Health Sciences Centre, University Hospital, London, Ontario, Canada.

^* To whom correspondence should be addressed. E-mail: dhackam{at}uwo.ca.

Key words: ACE inhibitors • angiotensin receptor blockers • antihypertensive agents • cerebrovascular disease • health policy • hypertension • medical Rx • outcomes • prevention • randomized controlled trials • stroke care • therapy